AUCTORES
Globalize your Research
Case Report | DOI: https://doi.org/10.31579/2641-0419/116
1Department of Cardiovascular Medicine, Kizilisu Krighiz, The People’s Hospital of Kizilisu Kirghiz Autonomous Prefecture, Xinjiang, China.
2Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University.
*Corresponding Author: Yanrong Liu and Dianfu Li, Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University.
Citation: Tianbao Xu, Esmayilaji Patiway, Gulistan Alim, Chenghui Tong, Jinghe Zhao, Patigul Rozi, Eslamgul Hayrilla, Zemu Wang, Dianfu Li, Yanrong Liu (2020) Coronary Artery Embolism and Antiphospholipid Syndrome: A Case Report and Review of the Literature. J. Clinical Cardiology and Cardiovascular Interventions, 3(13); Doi:10.31579/2641-0419/116
Copyright: © 2020 Yanrong Liu and Dianfu Li, This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 27 November 2020 | Accepted: 01 December 2020 | Published: 09 December 2020
Keywords: coronary embolism; antiphospholipid syndrome; anticoagulation; hydroxychloroquine (HCQ); statins.
Coronary artery embolism is an uncommon cause of acute myocardial infarction (AMI), while antiphospholipid syndrome (APS) is one of the rare reasons due to premature AMI. Coronary angiography can diagnose coronary artery embolism, and the positive serum of aPLs may infirm APS. We report a 32 years old man with ST-elevation AMI, without any high-risk factors of coronary artery disease. Coronary thrombosis was founded in the M1 sub-coronary of Left Anterior Descending (LAD), and the coronary artery was recanalized, the artery was not obstructive, Thrombolysis in Myocardial Infarction (TIMI) grade was III. He became shortness after exercise, the echocardiography showed his left ventricular was enlarged and LVEF was decreased. High titers of an anticardiolipin antibody (aCL) IgG of 46U (positive >20.0U), and it was positive at two dosages with an interval greater than 12 weeks. But there was no evidence of any other serum markers suggesting other associated pathologies such as SLE, so the primary APS was diagnosed. We gave him anticoagulation with warfarin and a single antiplatelet with Aspirin, the target INR was 2.5-3.0. Meanwhile, statins and hydroxychloroquine (HCQ) were all prescribed. After 6-months follow-up, his heart failure symptoms were disappeared, the LVDd and LVEF were all normal, the titer was decreased to nearly normal. In clinical background, young AMI without traditional high-risk factors of CAD, we should suspect APS. Therefore, we believed that HCQ may low thrombotic rate, down-trending aPLs titer, and prevent thrombotic recurrences in patients with primary antiphospholipid syndrome.
Coronary artery embolism is an uncommon cause of acute myocardial infarction (AMI), being identified as an etiology in 3-4% of the diagnosed cases, and it is easy to be ignored in clinical practice [1]. AMI is rarely associated with antiphospholipid syndrome (APS), therefore, the development of thrombosis in the coronary arteries is highlighted, and it is estimated that approximately 2.8-5.5% of cases of AMI in young individuals are secondary to APS [2].
The APS is defined by a state of hypercoagulability secondary to a wide spectrum of presentations. Its presentation is quite variable, constituting a spectrum of findings ranging from the presence of cutaneous alterations to the involvement of multiple organs, leading to systemic collapse. It is associated with thrombotic events involving venous and arterial territories, large arteries and veins as well as microvascular circulation and obstetrical events, in association with persistent antiphospholipid antibodies (aPLs), one or more of lupus anticoagulant (LA), and anticardiolipin antibodies (aCL) and /or IgM anti-beta 2 glycoprotein 1(ß2GP1) [3], which are implicated in the development of endothelial dysfunction among the factors. This syndrome is classified as primary when there is no association with other pathologies or secondary when it is linked to an underlying disease [4].
In APS, the mechanism of myocardial ischemia differs from that which occurs classically in coronary artery disease, a fact that implies the need for a specific therapeutic approach for patients with this syndrome [5].
Herein, we describe the case of a patient with APS who had AMI with ST-segment elevation on electrocardiogram and subsequent coronary stent thrombosis and then the thrombosis was autolysis. But the myocardial cells were damaged, left ventricular was enlarged and the LVEF was decreased.
Case Presentation
A young Chinese man, 32 years old, was admitted with chest pain for six hours in 6 months before, according to the ECG of V1-V4 ST elevation (Figure 1) and increased troponin T, the diagnosis of AMI was confirmed.
The laboratory findings were as follows: hemoglobin, platelets count, prothrombin time, liver and renal functions were all normal. But the troponin T and NT-proBNP were elevated. He received dual antiplatelet aggregation therapy (aspirin and Ticagrelor) and performed with coronary angiography after 6 hours of the symptom onset. Coronary thrombosis was founded in the M1 sub-coronary of LAD, and the coronary artery was recanalized, the artery was not obstructive, TIMI grade was III (Figure 2).
On the 20 days after discharge, the patient was readmitted with fatigue and a little shortness while he was climbing upstairs. During the laboratory evaluation, there was no significant change in the results, except for high titers of an anticardiolipin antibody IgG of 46U (positive >20.0U) and IgM of 14.6U (negative < 20.0U) and anti-β2-Glycoprotein I with IgG of 10.6RU/ml (negative < 20.0RU/ML). This test result was positive at two dosages with an interval greater than 12 weeks, there was no evidence of any other serum markers suggesting other associated pathologies such as SLE.
The myocardial scintigraphy with Thallium-201 at rest was performed to evaluate myocardial viability on 1-month of re-hospitalization, demonstrating viability associated with LAD artery territory [6]. It was an abnormal motion of the left ventricular and the left ventricular was enlarged (Figure 3).
Transthoracic echocardiography was also demonstrated that the left ventricular was enlarged (LVDd 59mm) the ejection fraction was decreased as 43.8%, and akinesis of segments: basal anterior septal, mid-anterior septal [7].
As such, primary APS was diagnosed according to the Sydney consensus statement on classification of APS [8] and oral anticoagulation (Warfarin) plus low-dose aspirin（LDA）. Hydroxychloroquine (HCQ, 400mg/day, 200mg twice a day) and statin (fluvastatin 80mg/day) with early outpatient follow-up were indicated [9]. According to the patient has symptoms and signs of heart failure, ACEI, beta-blocker, and spirolactone were added to anti-heart failure, and we added ACEI and beta-blocker and tittered to target dosage gradually.
This patient is a young man without any other high-risk factors of coronary artery disease. The diagnosis of APS was established by the presence of antipholipid antibodies and coronary thrombosis formation and the cTnT was higher and the evolution of ECG characteristics.
We followed him six months, the anticardiolipin antibody IgG of 27.8U and IgM of 15.6U, anti-β2-Glycoprotein I with IgG of 10.7 RU/ml (negative < 20.0RU/ML), NT-proBNP <5.0pg/mL, D-dimer 0.18mg/L. The echocardiography showed that LVDd 49mm, LAD 36mm, EF was normal. And six minutes’ walk was 602 miles, and we prescribed him for Mon-antiplatelet therapy of Aspirin and antithrombotic agents of warfarin adjusted the INR between 2.5-3.0.
Literature Review and Discussion
The pathology of acute coronary syndrome involves coronary thrombosis and platelet accumulation(10). Acute Coronary Syndrome (ACS) is categorized into unstable pectoris, ST-segment elevation, and non-ST-segment elevation. Coronary embolism is uncommon and is difficult to distinguish from other causes of AMI solely based on symptoms. The common risk factors of ST-segment myocardial infarction were hypertension, diabetes mellitus, dyslipidemia, glucocorticoid use, and smoking [11]. If a young male suddenly appears as AMI, without any atherosclerotic risk factors, but with a history of one of the following: atrial fibrillation, endocarditis, valve replacement, or venous thrombosis should be suspected as coronary embolism, while APS was an uncommon cause of coronary embolism. In this case, the patient did not have such risk factors as mentioned above, so we believed that the hypercoagulable state resulting from APS contributes to the progression and development of ST-elevation myocardial infarction.
Since the first description of APS in 1983, a long way has already been overcome [12]. However, new exciting knowledge is coming up in this field since the wider awareness of this disease has increased in interest. The heart is an important target organ in APS. Cardiac manifestations of APS include heart valve disease, stenotic or occlusive thrombotic coronary artery disease, intracardiac thrombus, left ventricular hypertrophy and dysfunction, and pulmonary hypertension. Myocardial small vessel involvement can be highly prevalent in APS patients [13].
APS may be a cause of coronary embolism as these above situations are absent [14]. Typically, APS has 3 major presentations: arterial and venous thrombosis, pregnancy loss and thrombocytopenia. Clinically, APS patients are divided into 4 types: I, positive for at least one laboratory indicator; type IIa, only positive for LA; type IIb, only positive for aCL; type IIc, only positive for ß2GP1 [15].
The frequency of myocardial infarction in patients with APS is reportedly 4% and the presence of antiphospholipid antibodies has been associated with myocardial infarction in young patients [16] There is an increased risk of myocardial infarction in patients with APS caused by coronary thrombosis rather than by premature atherosclerosis.
Anticoagulation should be achieved with warfarin or a novel anticoagulant rather than antiplatelet drugs [17]. Patients who received a coronary stent at the time of coronary angiography are more complex. Management may either be with triple therapy or a single antiplatelet agent coupled with oral anticoagulation, such as warfarin and Aspirin. Again, in the absence of guidelines, decisions are at the discretion of the individual clinician and assessment of bleeding risk against the risk of further thromboembolic events [18]. If the underlying vessel appears free of atherosclerosis according to coronary angiogram and without implanting the stent, the patient may be managed with anticoagulation alone.
Standard-of-care secondary thromboprophylaxis with dose-adjusted VKAs such as warfarin has several drawbacks, including adverse interactions with food and other drugs, the need for careful monitoring to keep patients with a desired range of the international normalized ratio (INR) and increased risk of bleeding [19]. The Non-Vitamin K Antagonists Oral Anticoagulants (NOACs,) are designed to provide predictable anticoagulation that can be delivered at a consistent dose and that does not require continuous monitoring [20]. But there are possible disadvantages to their use because of their pharmacokinetic profiles. Unlike warfarin, direct oral anticoagulants (DOACs) have only 1 molecular target so could be less effective in potent thrombophilic states. Anticoagulant doses needed to prevent arterial thrombosis are higher, so DOACs may not be adequate. Lastly, DOACs short half-lives may theoretically lead to additional “breakthrough” thrombosis and anticoagulation failures. Evidence is needed before we can widely adopt the use of DOACs in these high-risk populations [21]. DOACs role in the therapy of APS is under investigation but not verified [22]. It seems clear that the identification of subgroups of patients with distinct clinical features will allow a more precise therapeutic strategy and better patients care. However, the best clustering strategy is still a matter of debate. Probably, several other underappreciated factors might influence the risk of moving the balance to or away from the thrombotic state [23].
The actual mechanism of thrombosis in APS is as yet unknown, but numerous mechanisms have been proposed. Mammalian target of rapamycin (mTOR) is associated with APS-related vasculopathy. Of note, a growing pool of evidence suggests that mTOR inhibitors might induce a prothrombogenic phenotype in patients, leading to thrombosis and limiting their use in patients with aPL [24]. mTOR inhibitors such as sirolimus may be especially useful in APS patients with AMI requiring percutaneous intervention (PCI) to decrease in-stent vascular proliferation occurring several months after stent implantation [25].
The relapse rate in APS remains high, around 20%-21% at 5 years in thrombotic APS. Several pharmacological mechanisms explain the therapeutic potential of Hydroxychloroquine in rheumatic and related diseases. Hydroxychloroquine (HCQ) has various immunomodulatory, metabolic, cardiovascular, antithrombotic, and antineoplastic effects [26]. And HCQ has shown its efficacy in primary and secondary thromboprophylaxis, both in aPL positive and aPL negative SLE patients. HCQ could exert its anti-thrombotic ability through more than one mechanism and it shows an excellent safety profile [27]. HCQ can low thrombotic rate, down-trending aPL titer, and prevent thrombotic recurrences in patients with systemic lupus erythematosus and recently also in patients with primary antiphospholipid syndrome [28]. Despite the promising result, further evidences are needed in order to confirm the effective role of HCQ in preventing thrombotic recurrences in APS setting.
The patient’s decreased titer of aPL maybe relate to the HCQ, according to the previous studies, although other studies did not confirm this association. The titers of aPL frequently decrease and eventually become negative during the follow-up period [29]. The negativization has been related to a lower risk of thrombotic event, allowing to discontinuation of anticoagulation after aPL seroconversion seems to be reasonably safe, at least in primary APS [30].
While APS patients’ autoantibodies to phospholipid-binding proteins are thought to be pathogenetic through a variety of mechanisms, including interacting with the coagulation and fibrinolytic systems, monocyte and neutrophil activation, endothelial cell activation, and complement-mediated processes [31]. Statins are widely used for the treatment of hypercholesterolemia and in secondary prevention of atherosclerotic coronary disease. Stains have pleiotropic effects including the inhibition of vascular adhesion molecules, interleukin 6, and tissue factor in endothelial cells. In humans, Fluvastatin has been shown to significantly reduce pro-inflammatory and prothrombotic markers in APS patients [32].
Conclusions
Coronary embolism is uncommon in young adults and generally presents with chest pain and dyspnea. The diagnosis of coronary embolism is made definitively by cardiac catheterization. Echocardiography is needed to explore the origin of the thrombus. The antiphospholipid syndrome may be one of the etiologies. Thus, immunological tests should be performed. Long-term anticoagulant and antiplatelet therapies are recommended. HCQ and statins may reduce the titer of aPL to reduce the recurrence of coronary artery thrombosis. But we need more studies and case-control studies to confirm this conclusion. It is still needed to clarify if the future integration of artificial intelligence and big data to patient care might help in the management of the patients with APS considering hundreds of other risk factors unappreciated until now.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
